Universal Vision Biotechnology Past Earnings Performance
Past criteria checks 5/6
Universal Vision Biotechnology has been growing earnings at an average annual rate of 33.5%, while the Healthcare industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 25.9% per year. Universal Vision Biotechnology's return on equity is 31.8%, and it has net margins of 25.6%.
Key information
33.5%
Earnings growth rate
33.5%
EPS growth rate
| Healthcare Industry Growth | 9.1% |
| Revenue growth rate | 25.9% |
| Return on equity | 31.8% |
| Net Margin | 25.6% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Universal Vision Biotechnology (GTSM:3218) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 03
The Case For Universal Vision Biotechnology Co., Ltd. (GTSM:3218): Could It Be A Nice Addition To Your Dividend Portfolio?
Mar 26Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mar 08The 22% Return On Capital At Universal Vision Biotechnology (GTSM:3218) Got Our Attention
Feb 07Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 17
Universal Vision Biotechnology (GTSM:3218) Seems To Use Debt Rather Sparingly
Dec 27Estimating The Fair Value Of Universal Vision Biotechnology Co., Ltd. (GTSM:3218)
Dec 06Revenue & Expenses BreakdownBeta
How Universal Vision Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4,082 | 1,045 | 1,137 | 0 |
| 30 Sep 23 | 4,047 | 1,036 | 1,160 | 0 |
| 30 Jun 23 | 3,897 | 976 | 1,150 | 0 |
| 31 Mar 23 | 3,687 | 903 | 1,108 | 0 |
| 31 Dec 22 | 3,494 | 851 | 1,059 | 0 |
| 30 Sep 22 | 3,273 | 791 | 1,008 | 0 |
| 30 Jun 22 | 3,032 | 719 | 949 | 0 |
| 31 Mar 22 | 2,857 | 659 | 910 | 0 |
| 31 Dec 21 | 2,632 | 595 | 868 | 0 |
| 30 Sep 21 | 2,469 | 538 | 834 | 0 |
| 30 Jun 21 | 2,399 | 556 | 792 | 0 |
| 31 Mar 21 | 2,269 | 543 | 733 | 0 |
| 31 Dec 20 | 2,053 | 483 | 671 | 0 |
| 30 Sep 20 | 1,865 | 422 | 633 | 0 |
| 30 Jun 20 | 1,628 | 322 | 590 | 0 |
| 31 Mar 20 | 1,503 | 281 | 579 | 0 |
| 31 Dec 19 | 1,419 | 238 | 570 | 0 |
| 30 Sep 19 | 1,340 | 226 | 535 | 0 |
| 30 Jun 19 | 1,285 | 214 | 523 | 0 |
| 31 Mar 19 | 1,233 | 188 | 512 | 0 |
| 31 Dec 18 | 1,195 | 161 | 508 | 0 |
| 30 Sep 18 | 1,165 | 144 | 501 | 0 |
| 30 Jun 18 | 1,144 | 146 | 484 | 0 |
| 31 Mar 18 | 1,107 | 130 | 471 | 0 |
| 31 Dec 17 | 1,082 | 120 | 458 | 0 |
| 30 Sep 17 | 1,085 | 131 | 453 | 0 |
| 30 Jun 17 | 1,068 | 102 | 460 | 0 |
| 31 Mar 17 | 1,072 | 96 | 464 | 0 |
| 31 Dec 16 | 1,073 | 92 | 477 | 0 |
| 30 Sep 16 | 1,038 | 62 | 475 | 0 |
| 30 Jun 16 | 1,031 | 75 | 477 | 0 |
| 31 Mar 16 | 1,014 | 69 | 479 | 0 |
| 31 Dec 15 | 1,014 | 81 | 473 | 0 |
| 30 Sep 15 | 1,016 | 89 | 476 | 0 |
| 30 Jun 15 | 1,013 | 92 | 468 | 0 |
| 31 Mar 15 | 1,000 | 93 | 456 | 0 |
| 31 Dec 14 | 988 | 102 | 447 | 0 |
| 30 Sep 14 | 992 | 119 | 439 | 0 |
| 30 Jun 14 | 972 | 118 | 426 | 0 |
| 31 Mar 14 | 945 | 107 | 425 | 0 |
| 31 Dec 13 | 916 | 86 | 427 | 0 |
| 30 Sep 13 | 853 | -3 | 427 | 0 |
| 30 Jun 13 | 809 | -43 | 435 | 0 |
Quality Earnings: 3218 has high quality earnings.
Growing Profit Margin: 3218's current net profit margins (25.6%) are higher than last year (24.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3218's earnings have grown significantly by 33.5% per year over the past 5 years.
Accelerating Growth: 3218's earnings growth over the past year (22.9%) is below its 5-year average (33.5% per year).
Earnings vs Industry: 3218 earnings growth over the past year (22.9%) exceeded the Healthcare industry 7.6%.
Return on Equity
High ROE: 3218's Return on Equity (31.8%) is considered high.